Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Rosen

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screeningShengqing Gu, Stephanie Lheureux, Azin Sayad, et al.
Gynecologic Oncology|April 9, 2013
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort studyYakir Segev, Javaid Iqbal, Jan Lubinski, et al.
The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|January 27, 2010
Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutationKelly A Metcalfe, Parviz Ghadirian, Barry Rosen, et al.
Nature|June 17, 2011
A conditional knockout resource for the genome-wide study of mouse gene functionWilliam C Skarnes, Barry Rosen, Anthony P West, et al.
Journal of the National Cancer Institute|September 25, 2008
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriersAndrea Eisen, Jan Lubinski, Jacek Gronwald, et al.
International Journal of Cancer|January 16, 2008
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersKelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, et al.
Gynecologic Oncology|July 4, 2012
Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking PartnershipCamille Maringe, Sarah Walters, John Butler, et al.
Annals of Surgical Oncology|April 29, 2020
Legacy Genetic Testing Results for Cancer Susceptibility: How Common are Conflicting Classifications in a Large Variant Dataset from Multiple Practices?Kanhua Yin, Yuxi Liu, Basanta Lamichhane, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2021
Correction of a urea cycle defect after ex vivo gene editing of human hepatocytesMihaela Zabulica, Raghuraman C Srinivasan, Pinar Akcakaya, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screeningShengqing Gu, Stephanie Lheureux, Azin Sayad, et al.
Gynecologic Oncology|April 9, 2013
The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort studyYakir Segev, Javaid Iqbal, Jan Lubinski, et al.
The Lancet. Oncology|January 2, 2007
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control studyJohn R McLaughlin, Harvey A Risch, Jan Lubinski, et al.
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|January 27, 2010
Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutationKelly A Metcalfe, Parviz Ghadirian, Barry Rosen, et al.
Nature|June 17, 2011
A conditional knockout resource for the genome-wide study of mouse gene functionWilliam C Skarnes, Barry Rosen, Anthony P West, et al.
Journal of the National Cancer Institute|September 25, 2008
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriersAndrea Eisen, Jan Lubinski, Jacek Gronwald, et al.
International Journal of Cancer|January 16, 2008
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersKelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, et al.
Gynecologic Oncology|July 4, 2012
Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking PartnershipCamille Maringe, Sarah Walters, John Butler, et al.
Annals of Surgical Oncology|April 29, 2020
Legacy Genetic Testing Results for Cancer Susceptibility: How Common are Conflicting Classifications in a Large Variant Dataset from Multiple Practices?Kanhua Yin, Yuxi Liu, Basanta Lamichhane, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2021
Correction of a urea cycle defect after ex vivo gene editing of human hepatocytesMihaela Zabulica, Raghuraman C Srinivasan, Pinar Akcakaya, et al.
Pageof 15